Prakt. lékáren. 2015; 11(4): 141-143

Over-the-counter medicines for headaches - proper selection and possible risks

Ingrid Niedermayerová
Neurologická ambulance Quattromedica Brno

Over-the-counter (OTC) analgesics are divided according to their clinical effect structure to analgesics – anti-inflammatory drugs

(ibuprofen, naproxen, diclofenac, dexketoprofen) and analgetics–antipyretics (acetylsalicylic acid, paracetamol, propyphenazone), and

according to the number of substances to simple and combined analgesics. OTC analgesics are used in the treatment of migraine, tension-

type headache and minor secondary headaches. The choice of the drug depends on the intensity of pain, the presence of associated

symptoms, other used medications (warfarin, aspirin, other nonsteroidal anti-inflamatory drugs, corticosteroids, antidepressants, oral

antidiabetic drugs) and complicating diseases (stomach and duodenal ulcers, arterial hypertension, coronary artery disease, bronchial

asthma, disease of liver and kidney). Polymorbid persons have higher risk of interactions OTC analgesics with other frequent medication.

Medical examination should be recomended to people with a higher frequency of headaches and suspected abuse of analgesics.

Keywords: OTC analgesics, nonsteroidal anti-inflammatory drugs, headache

Published: September 15, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Niedermayerová I. Over-the-counter medicines for headaches - proper selection and possible risks. Praktické lékárenství. 2015;11(4):141-143.
Download citation

References

  1. The Headache Classification Committee of the International Headache Society: The International Classification of Headache Disorders. 3rd edition (beta version). Cephalgia 2013; 33(9): 629-808. Go to original source... Go to PubMed...
  2. Rokyta R, Kršiak M, Kozák J. Bolest. Praha: Tigis 2006: 684.
  3. Opavský J. Bolest v ambulantní praxi. Maxdorf Jessenius, 2011: 398.
  4. Opavský J, Kršiak M, Miloschewsky D. Farmakologie a farmakoterapie bolesti. Bolest 2000; Suppl. 1(1-12).
  5. Praško JP, Látalová K, Marková J, Vondráčková D, Kašparová L, Novotná H. Brevíř 2011/2012. Psychiatrie/neurologie/léčba bolesti, třetí doplněné a rozšířené vydání. Praha: Medical Tribune, 2011: 1064.
  6. Straube A, Aicher B, Fiebich BL, Haag G. Combined analgesics in (headache) pain therapy: shotgun approach or precise multi-target therapeutics? BMC Neurology 2011; 1: 43. Go to original source... Go to PubMed...
  7. Pfaffenrath V, Diener H, Pageler L, Peil H, Aicher B. OTC analgesics in headache treatment: Open label phase vs randomsed double-blind phase of large clinical trial. Headache 2009; 49: 638-645. Go to original source... Go to PubMed...
  8. Laska EM, Sunschine A, Mueller F, Evers W, Siegel C, Rubin A. Caffein as an analgesics adjutant. JAMA 1984; 251(13): 1711-1718. Go to original source...
  9. SPC Guajacuran. Dostupný z www: http://www.sukl.cz/modules/medication/search.php
  10. Diklofenak - CMDh schválila doporučení Výboru PRAC. Dostupný na www: http://www.sukl.cz/diklofenak-cmdh-schvalila-doporuceni-vyboru-prac.
  11. Evers S, Áfra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. European Journal of Neurology. 2009; 16: 968-981. Go to original source... Go to PubMed...
  12. Bendtsen L, Evers S, Linde M, Mitsikostas DD, Sandrini G, Schoenen J. EFNS guideline on the treatment of tension-type headache. Report of an EFNS task force. Eur J Neurol 2010; 17: 1318-1325. Go to original source... Go to PubMed...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.